Plasma fibrinogen is a mixture of multiple molecular forms arising mai
nly through alternative mRNA processing and subsequent posttranslation
al modification. Recombinant fibrinogen is synthesized without alterna
tive mRNA processing in a cultured cell system that may generate novel
posttranslational modifications. Thus, to show that recombinant fibri
nogen can serve as a functional model for plasma fibrinogen, we have e
xamined the conversion of fibrinogen to fibrin, comparing the recombin
ant with the plasma protein, We examined the kinetics of (1) thrombin-
catalyzed fibrinopeptide release, (2) thrombin-catalyzed polymerizatio
n of fibrinogen, (3) the polymerization of fibrin monomers, and (4) FX
IIIa-catalyzed cross-link formation. We saw small differences in polym
erization, suggesting that the ordered assembly of protofibrils and fi
bers was not identical, In all other analyses, we found that plasma fi
brinogen and recombinant fibrinogen were remarkably similar. Using ele
ctron microscopy, we examined the structures of individual fibrinogen
molecules and fibrin clots. Individual fibrinogen molecules were predo
minantly three nodule structures for both recombinant and plasma prote
ins, Both samples also displayed four nodule structures, but fewer fou
r nodule structures were found with recombinant fibrinogen. Fibrin clo
t structures were essentially indistinguishable. We concluded that rec
ombinant fibrinogen can serve as a accurate model for plasma fibrinoge
n. (C) 1997 by The American Society of Hematology.